
Hi {{ first name | there}},
Last week's poll made the pattern pretty clear: 50% of readers said the biggest takeaway was realizing that prediabetes could already be a blood-vessel problem, while only 23% picked the fruit angle itself.
That is exactly the kind of story we want to keep finding here: not just something useful, but something that makes a familiar topic feel suddenly more serious, more surprising, or more important than it first looked.
This week is one of those stories.
Most people still file strength training under a familiar set of benefits: muscle, shape, bone density, healthier aging.
All true.
But a new trial suggests that framing may be too narrow.
Evidence-first health, delivered – and built.
And if this issue changes how you think about strength training, forward it to one person who still sees lifting as optional unless muscle is the goal. Subscribe here.
Want the full Deep Dive? Upgrade to HEALTH HACK Pro and the Pro sections unlock on the web version right away.
-LONGEVITY PLAYBOOK-
Lifting Weights Slowed "Brain Age" in a New Trial

That is not how most people think about lifting.
Strength training is usually treated as a body story: more muscle, better shape, stronger bones, healthier aging.
But a new randomized trial suggests the story may be bigger than that. In adults aged 62–70, one year of resistance training significantly reduced brain-age gap – by roughly 1.4–2.3 years, depending on the group and time point – while the control group did not. And notably, improvements in leg strength tracked with improvement in that brain-aging signal.
That does not prove lifting prevents dementia or makes anyone instantly sharper.
It does suggest something more interesting: the habit many people still file under "muscle" may also be one of the more underappreciated brain-maintenance habits.
The study matters because it moves beyond the usual "exercise is good for the brain" line. This was not mainly a cardio story, and it was not just a questionnaire story about mood or self-reported wellbeing. It was a one-year resistance-training intervention linked to measurable changes in an MRI-based model of functional brain aging. The researchers found that both heavy and moderate-intensity resistance training reduced brain-age gap, while heavy training also increased favorable prefrontal functional connectivity.
That does not mean the participants' brains literally became 2 years younger in every meaningful sense. A brain-age gap is a modeled signal, not a direct clinical endpoint. It reflects how "old" the brain looks according to a trained imaging model compared with chronological age. So the honest read is not, "lifting reversed aging." The honest read is that a long-term strength-training habit shifted whole-brain function in a younger-looking direction.
There is another detail that makes this more than a clever headline: the effect did not look like a tiny local quirk. The authors argue it appeared more global than local, suggesting that resistance training may influence broader brain systems rather than just a single motor or coordination network. And while the link between leg-strength gains and brain-age improvement was modest, it points toward something important: this may not be a "do curls for your brain" story. It looks more like whole-body strength work affecting whole-brain function.
That broader interpretation also fits the wider literature. Recent meta-analyses suggest resistance training can improve overall cognitive function in older adults, with signals in areas like working memory, verbal learning and memory, and global cognition. A 2025 network meta-analysis even found resistance training to be the most effective exercise mode for improving global cognitive function and inhibitory control in cognitively healthy older adults.
Why might that happen?
Probably not for one magical reason. The plausible mechanisms run through several lanes at once: better insulin sensitivity, better vascular function, lower inflammatory load, higher neurotrophic signaling, and the simple fact that producing force is a full-system task. Strength training is not only about muscles pulling on bones. It is also about the nervous system coordinating effort, stabilizing position, generating power, and adapting to repeated challenge. That is one reason treating lifting as a vanity habit undersells it so badly.
This is also why the story feels timely.
The public brain-health conversation is still crowded with sleep gadgets, supplements, cognitive games, and cardio-centric advice. Strength training often gets reduced to a side benefit – good for looks, good for metabolism, good for "aging well" in some vague sense. But this trial suggests that framing may be too narrow. Lifting may belong much closer to the center of the brain-health conversation than most people think.
Reality check
Before anyone turns this into "2 weeks of dumbbells makes you smarter," slow down.
The anchor study was in older adults, not every age group. The intervention lasted one year, not 14 days. The outcome was a brain-clock model based on resting-state fMRI, not dementia incidence, IQ, or daily work performance. And while the result is genuinely exciting, it is still one piece of evidence in a field where the mechanisms are plausible, but not fully settled.
So the strongest honest promise this week is not:
"Lift now, get a younger brain by next month."
It is this:
If you have been treating lifting as optional unless you care about muscle, you may be underestimating one of the most important reasons to do it.
Continue in HEALTH HACK Pro: what the "brain age" result probably means in real life – and what it definitely does not.
THE PROTOCOL
The Brain-Lift 3–2–1 Block

This is not the study protocol. It is the field version.
The anchor trial used a 1-year, structured resistance-training intervention in adults aged 62–70. Your 14-day job is not to "reproduce the MRI result." Your job is to install the pattern that could plausibly earn the long-term effect: consistent, full-body strength work with real lower-body effort. That emphasis is not random – in the study, changes in leg strength were significantly associated with changes in brain-age gap.
The rule
3 sessions per week
2 lower-body anchors every session
1 carry / balance finisher every session
Session template
1) Lower-body anchor #1
Choose one:
Goblet squat
Leg press
Weighted sit-to-stand
2) Lower-body anchor #2
Choose one:
Romanian deadlift
Hip hinge
Step-up
Split squat
Hip bridge
3) Upper push
Choose one:
Incline push-up
Dumbbell press
Machine press
4) Upper pull
Choose one:
Seated row
Band row
Lat pulldown
5) Finisher
Choose one:
Farmer carry
Suitcase carry
March in place with one dumbbell
Split-stance hold
How to run it
For the first four movements:
2–4 sets
6–10 controlled reps
Stop with about 1–2 reps in reserve
For the finisher:
3 rounds
20–40 seconds each round
Your 14-day goal
Do 6 sessions total.
Not perfect programming. Not heroic soreness. Not mirror-muscle fluff.
Just install the pattern.
Why this protocol is built this way
The point is not to mimic bodybuilding.
The point is to build a repeatable strength pattern that treats lifting as a whole-body brain-maintenance habit, not just a muscle habit. The study signal was not "arm day helps cognition." It was a broader resistance-training effect, with a meaningful link between lower-body strength and the brain-aging result.
Measurement instructions
At Day 0 and Day 14:
Test grip strength in both hands
Record your best score for each hand
Record your asymmetry
Record how many sessions you actually completed
Safety line
Skip this protocol if you have uncontrolled blood pressure, current chest pain, unexplained shortness of breath, recent surgery, acute back or joint injury, or any neurologic or orthopedic issue that makes loaded movement unsafe.
Stop and seek care for:
chest pressure
fainting
severe dizziness
pain that feels sharp, unstable, or escalating rather than muscular
The anchor trial excluded people with significant medical, musculoskeletal, or neurologic problems likely to interfere with training.
TINY SCOREBOARD
Copy/paste this and send it back after 14 days:
Sessions completed: __ / 6
Left grip strength: __ kg
Right grip strength: __ kg
Grip asymmetry: __ %
Most consistent lift: __
Biggest obstacle: __
Did you feel sharper, steadier, or more capable? __
Continue in HEALTH HACK Pro: the beginner, busy, and advanced versions of the Brain-Lift 3–2–1 Block, plus the 14-day tracker, troubleshooting guide, and stop rules.
-SPONSORED-
What 200K+ Engineers Read to Stay Ahead
Your GitHub stars won't save you if you're behind on tech trends.
That's why over 200K engineers read The Code to spot what's coming next.
Get curated tech news, tools, and insights twice a week
Learn about emerging trends you can leverage at work in just 5 mins a day
Become the engineer who always knows what's next
-BIOMARKER OF THE WEEK-
Grip strength
Grip strength is one of the most underrated health metrics in circulation.
Not because your hand is magical.
Because a hard squeeze is a cheap, portable proxy for neuromuscular reserve – your ability to produce force on demand through the combined work of muscle and nervous system. Lower grip strength has been linked to higher risk across multiple domains, including frailty, disability, cardiovascular disease, all-cause mortality, and cognitive decline. A large 2024 narrative review summarized the strength of that signal across aging and cardiometabolic outcomes.
That is why grip strength matters in this issue.
If the main story is that lifting may be doing more for the brain than most people assume, then the right biomarker is not a flashy nootropic score. It is a simple force-production marker that captures something bigger than "hand strength."
Why influencers usually explain this badly
Most influencer takes reduce grip strength to a single heroic number.
That misses the point.
Grip strength becomes much more useful when you read it in context:
Absolute strength matters
Body size matters
Age matters
Left-right asymmetry matters
Trend matters more than one isolated result
That is the real reason to track it.
Not to post one score online.
But to get a practical read on whether your system is becoming more capable, more fragile, or more uneven over time.
How to measure it properly
Use a hand dynamometer if you can.
For a cleaner reading:
test seated
keep your shoulder close to the body
keep your elbow at about 90 degrees
use the same handle setting each time
do 3 hard squeezes per hand
alternate hands
record the best score for each side
The key is not lab perfection. The key is consistency.
What "better" generally means
For older adults, one commonly used screen for low grip strength from the European Working Group on Sarcopenia in Older People (EWGSOP2) is:
below 27 kg for men
below 16 kg for women
Those are useful red-flag thresholds, not universal performance targets for every population. They help identify probable weakness, especially in older adults, but should not be treated like one-size-fits-all destiny.
Then there is asymmetry.
A rough practical rule:
a side-to-side difference above 10% deserves attention
above 20% is more concerning
Recent work suggests that grip weakness plus asymmetry may be more informative than a raw number alone when thinking about frailty, comorbidity, and aging risk.
So do not ask only:
"What is my grip number?"
Ask:
"What is my number, what is my asymmetry, and is the trend improving?"
That is the more useful question.
Continue in HEALTH HACK Pro: how to interpret grip strength properly by age, body size, asymmetry, and training status – and when a raw number is misleading.
-MYTH OF THE WEEK-
"Cardio is for the brain. Lifting is just for muscle."
That is outdated.
Cardio absolutely belongs in the brain-health conversation.
But the idea that resistance training is "just for muscle" no longer fits the evidence.
A 2025 systematic review and meta-analysis found that resistance training improved overall cognitive function, working memory, verbal learning and memory, and spatial memory in older adults. A separate 2025 network meta-analysis found resistance training was the most effective exercise modality for improving global cognitive function and inhibitory control in cognitively healthy older adults.
And this week's anchor study pushes that story further. In adults aged 62–70, one year of resistance training significantly reduced brain-age gap, while the control group did not.
That does not mean lifting replaces cardio.
It means the old division of labor is too simplistic.
Cardio is not the only exercise mode that matters for the brain. Strength training appears to belong in that conversation much more centrally than most people were taught.
Safer replacement belief
Use this instead:
Cardio matters for the brain. But lifting belongs in the brain-health conversation too.
That is the more accurate model.
And it leads to a better weekly plan than choosing one side of the false cardio-vs-lifting divide.
THE SUPPLEMENT
Trimethylglycine (TMG)

Trimethylglycine, also called betaine, is not a classic "brain booster."
That is part of why it fits this issue.
The strongest case for TMG here is not that it gives you a quick mental edge. It is that it sits at the intersection of methylation, homocysteine metabolism, and training adaptation. A 2024 narrative review concluded that results from human randomized trials suggest betaine can improve body composition when combined with physical activity and can lower serum homocysteine. The same review also noted an important caveat: doses >= 4 g/day have been associated with increases in total cholesterol and LDL cholesterol.
That makes TMG more interesting than the usual nootropic angle.
It is better framed as a training-support compound than as a "focus" supplement. In a 6-week resistance-training trial, betaine supplementation improved body composition, arm size, and bench-press work capacity, while not clearly improving maximal strength.
At the same time, the evidence is not clean enough to treat TMG like a guaranteed performance upgrade. A 2022 systematic review and meta-analysis found no significant overall benefit of betaine supplementation on body mass, BMI, fat mass, body-fat percentage, or lean mass across pooled studies.
What it is
TMG is a naturally occurring compound involved in methyl donation and one-carbon metabolism. It is present in foods, especially beets, and is also sold as a supplement. Older nutrition literature describes betaine as relevant to osmotic balance, methylation, and homocysteine handling.
Why it fits this issue
This week's issue is really about building a more serious strength-training pattern.
TMG fits that story better than a flashy "brain stack" because it is potentially relevant to:
training adaptation
body-composition support
methylation support
homocysteine reduction
In other words, it belongs more naturally in a long-horizon performance and resilience frame than in a "feel smarter in 20 minutes" frame.
Practical use framing
The best use case is not:
"I want a fast cognitive lift."
It is closer to:
"I am actually running a lifting block, and I want a supplement with at least some plausible support for training adaptation and methylation physiology."
That is the more adult decision rule.
Safety / caution
This is the part many summaries skip.
TMG is not a free win. The best current review-level summary says the lipid picture matters: while betaine can lower homocysteine, higher-dose use has also been associated with increases in LDL cholesterol and total cholesterol. That matters especially for readers already watching LDL-C, apoB, or overall cardiovascular risk.
So the correct posture is:
interesting, potentially useful, but not casual.
Continue in HEALTH HACK Pro: where TMG earns its place, where it is overhyped, and the LDL detail most supplement summaries skip.
-IN THE PRESS-
What we're reading
Oral GLP-1s just got more real
The FDA approved Eli Lilly's oral GLP-1 orforglipron (Foundayo), and the convenience angle is the real headline: unlike Novo's oral Wegovy, it does not require fasting or water timing rules. In a trial of more than 3,000 adults with obesity, the highest dose led to about 11.2% weight loss over more than 16 months.
ScienceAlert
Fish oil is not your LDL fix
New guidance says over-the-counter fish oil and other supplements are not recommended for lowering LDL cholesterol, and the article notes a more uncomfortable detail: some fish-oil products may even raise LDL and increase atrial fibrillation risk. Prescription icosapent ethyl is a different story – but that is not the same as casual supplement use.
Verywell Health
GLP-1 "super-responders" may be partly genetic
A large study of 27,885 GLP-1 users found that variants in GLP1R and GIPR help explain why some people lose much more weight – and why some get much worse nausea and vomiting. That is a useful reminder that poor response is not always "lack of discipline," and great response is not always "perfect protocol."
Neuroscience News
Mitochondria may have a cleaner genome-management trick than we thought
Researchers at EPFL report that mitochondria use a transient "pearling" shape change – basically a beads-on-a-string reorganization – to help distribute mitochondrial DNA more evenly. This is a good reminder that mitochondrial biology is still revealing surprisingly elegant control systems.
Phys.org
Psychedelics may share a common brain signature
A new analysis of more than 500 brain scans across 11 datasets found that LSD, psilocybin, DMT, mescaline, and ayahuasca all appear to increase cross-talk between brain systems, producing a shared "neural fingerprint." This is a useful signpost for where psychiatric and consciousness research is heading.
The Guardian
-PEPTIDE OF THE WEEK-
CJC-1295 (GHRH analog)

CJC-1295 is often presented as the "cleaner" growth-hormone peptide – the one that supposedly helps with recovery, body composition, sleep, and even "healthy aging" without sounding as crude as straight growth hormone. That is the promise.
The evidence gap is that the best-known human data behind CJC-1295 is much narrower than that marketing story. The classic human study showed that CJC-1295 produced sustained, dose-dependent increases in GH and IGF-1 in healthy adults, with an estimated half-life of about 5.8–8.1 days. What it did not establish was that CJC-1295 reliably improves the outcomes people usually care about in real life – better physique, better recovery, better cognition, or better long-term health.
So this week's peptide section is not here to tell you that CJC-1295 is "the answer." It is here to draw a clearer line between endocrine movement and decision-grade evidence.
What it is
CJC-1295 is a synthetic analog of growth hormone-releasing hormone, or GHRH. In simple terms, it is designed to stimulate the pituitary toward increased endogenous growth hormone release rather than replacing growth hormone directly.
And yes, the naming matters here: There is CJC-1295 with DAC and CJC-1295 without DAC.
DAC stands for Drug Affinity Complex. In practice, this is the modification designed to let the peptide bind to albumin and stay around much longer. The classic 2006 human paper is about the long-acting form of CJC-1295, and the FDA's 2024 PCAC materials describe CJC-1295 DAC free base as CJC-1295 free base with the MPA-lysine unit added to the C terminus.
That distinction matters because online peptide discussions often blur everything together as if "CJC-1295" were one clean thing with one clean evidence story. It is not.
The classic human endocrine data is about CJC-1295 with DAC. Meanwhile, CJC-1295 without DAC is listed separately by PubChem, which is one more reason readers should not casually assume that the same pharmacology or evidence applies across both forms.
That is also where tesamorelin becomes a useful comparator. Tesamorelin is also a GHRH analog, but unlike CJC-1295 it has an actual FDA-approved indication: reducing excess abdominal fat in HIV-infected adults with lipodystrophy. The label is also explicit about its limits: it is not indicated for weight loss management, and its long-term cardiovascular safety has not been established.
How it might work
At a high level, CJC-1295 may work by:
binding the GHRH receptor and stimulating pituitary GH release
increasing downstream IGF-1
preserving at least some degree of GH pulsatility
indirectly affecting tissue remodeling, substrate handling, and recovery through the GH–IGF-1 axis
creating a biologic signal that sounds impressive long before it proves a meaningful real-world outcome
The evidence: claims vs reality
Claim: CJC-1295 is a clinically solid muscle-and-recovery peptide.
Reality: The best direct human evidence shows that CJC-1295 with DAC raises GH and IGF-1 in healthy adults and was relatively well tolerated in early trials. That is real. But that is still an endocrine signal, not proof of better strength, better hypertrophy, better brain function, or better aging outcomes in the people most likely to buy into the hype.
Claim: CJC-1295 with DAC and CJC-1295 without DAC are basically the same thing.
Reality: They should not be treated that way. The classic human study is about CJC-1295 with DAC – the long-acting, albumin-binding form. Once you move into CJC-1295 without DAC, the kinetics and the naming context change, and readers should be more careful about assuming the same evidence applies.
Claim: CJC-1295 is basically the premium GH-axis option.
Reality: This is where the comparison with tesamorelin becomes useful. Tesamorelin has a much stronger clinical dossier. It has an FDA-approved indication and actual outcome data in a defined patient population. Same family does not mean same evidence.
Claim: Stacking CJC-1295 with ipamorelin makes the whole thing evidence-based.
Reality: It makes the stack more popular, not more proven. We will cover ipamorelin in a future issue, because it sits in a different GH-secretagogue lane and deserves its own review instead of being smuggled in here as a credibility upgrade. The 2026 WADA Prohibited List also explicitly names CJC-1295 and tesamorelin under GHRH analogues and separately bans growth hormone secretagogues.
Decision rule (what to do instead this week)
Do not use this issue as permission to drift into GH-axis peptide experimentation.
Use it as a reminder that the strongest lever in this week's issue is still training.
The move this week is:
run the Brain-Lift 3–2–1 Block
baseline your grip strength
treat TMG as optional and secondary
keep CJC-1295 in the "interesting, but not decision-grade for self-use" bucket
And keep the comparison straight:
the peptide with the louder gym reputation is not the one with the stronger clinical story.
Tesamorelin is the better-supported GHRH analog. CJC-1295 is the louder one.
Hard disclaimer (please read)
This section is educational only.
CJC-1295 belongs in clinic-only / research-watchlist territory. Do not self-source it. Do not confuse GH or IGF-1 movement with proven better outcomes. Do not assume that being popular in body-composition circles means the evidence is strong. And do not use this section as a substitute for clinician-guided decisions around endocrine issues, liver fat, visceral adiposity, performance-enhancing drugs, or HIV-associated lipodystrophy.
Continue in HEALTH HACK Pro: the CJC-1295 with DAC vs CJC-1295 without DAC distinction, the CJC-1295 vs tesamorelin comparison most peptide discussions get wrong, and why ipamorelin is next.
QUICK POLL
Which part of this issue changed your thinking most?
- 🧠 "I did not realize lifting could have this kind of brain-aging angle."
- 🏋️ "The brain-age study changed how I think about strength training."
- 🤝 "Grip strength suddenly feels much more important than I thought."
- 🧬 "The CJC-1295 with DAC vs without DAC distinction changed how I think about peptide hype."
- ⚖️ "The tesamorelin comparison made the whole peptide story feel much clearer."
- 👍🏼 "The Brain-Lift 3–2–1 Block feels like something I will actually do."
-SPONSORED-
Daily news for curious minds.
Be the smartest person in the room. 1440 navigates 100+ sources to deliver a comprehensive, unbiased news roundup — politics, business, culture, and more — in a quick, 5-minute read. Completely free, completely factual.
QUOTE TO REMEMBER
💡 The habits that protect your future are often the ones people mistake for vanity in the present.
Closing Note
The best health systems are not built on hype.
They are built on noticing which really important habits have been hiding in plain sight.
This week, that habit is not a fancy stack. It is not a clever shortcut. It is a more serious way of thinking about strength training.
If you run The Brain-Lift 3–2–1 Block, reply with your scoreboard.
And if this week's issue changed how you think about lifting, forward it to one person who still thinks strength training is only about muscle.
Until next time,
Live longer. Upgrade wisely.
Rolf & the HEALTH HACK team
PS: If someone sent you this, you can subscribe here: HEALTH HACK Newsletter
Disclaimer
Educational only. Not medical advice. Do not delay care. Consult your clinician for personal decisions – especially around symptoms, imaging, supplements, medications, or peptides. Do not self-source peptides.

